Unlocking boron's medical promise
AN2 Therapeutics (an2therapeutics.com) scores 71 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, in the 27th percentile of 19087 Healthcare brands.
AN2 Therapeutics is a biopharmaceutical company that develops medicines using a proprietary boron chemistry platform. The company focuses on creating first-in-class therapeutics for infectious diseases and cancers where current treatment options are limited. Its work targets patients with serious, unmet medical needs, as well as healthcare providers, researchers, and investors in the biopharmaceutical sector. AN2 Therapeutics positions itself as a pioneer in applying boron's unique chemical properties to drug discovery.
| Brand Name | AN2 Therapeutics |
|---|---|
| Domain | an2therapeutics.com |
| Industry | Healthcare |
| Main Competitors | Anacor Pharmaceuticals, Spero Therapeutics (75/100), Paratek Pharmaceuticals (75/100), Melinta Therapeutics (74/100), Bugworks Research (74/100) |
Moz Domain Authority 34/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #2,719,465 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "AN2 Therapeutics develops breakthrough medicines through our boron chemistry platform, advancing therapies for infectious diseases and cancer worldwide." (Meta description: 18 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, X (Twitter), Instagram; no detected presence on Facebook, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
AN2 Therapeutics's main competitors in Healthcare: Spero Therapeutics (75/100), Paratek Pharmaceuticals (75/100), Melinta Therapeutics (74/100), Bugworks Research (74/100).
Sources: Brand Analyzer scan
AN2 Therapeutics has low AI-search visibility, scoring 24/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 42, recommendation 45). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: AN2 Therapeutics official site
AN2 Therapeutics scores 45/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: AN2 Therapeutics official site
AN2 Therapeutics is a biopharmaceutical company that develops novel medicines using a proprietary boron chemistry platform. It focuses on creating first-in-class therapies for infectious diseases and cancers, particularly those with limited existing treatment options.
Sources: AN2 Therapeutics official site
AN2 Therapeutics discovers and develops breakthrough medicines by leveraging the unique chemical properties of boron. The company applies this boron chemistry platform to design novel therapeutics aimed at infectious diseases and cancers where current treatment options are inadequate.
Sources: AN2 Therapeutics official site
AN2 Therapeutics can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: AN2 Therapeutics official site
AN2 Therapeutics is known for its proprietary boron chemistry platform, which it uses to develop first-in-class medicines for infectious diseases and cancer. The company positions itself as a pioneer in applying boron-based chemistry to address serious, unmet medical needs.
Sources: AN2 Therapeutics official site
AN2 Therapeutics' work is intended for patients suffering from infectious diseases and cancers with limited treatment options. Its activities also involve healthcare providers, researchers, and investors within the biopharmaceutical industry who engage with its drug development programs.
Sources: AN2 Therapeutics official site
AN2 Therapeutics scores 24/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
AN2 Therapeutics has a weak AI-visibility profile at 24/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (45/100) and its weakest is visibility (0/100). It benefits from a global traffic rank of #2,719,465 (Tranco), open access for AI crawlers (GPTBot, ClaudeBot, etc.) and machine-readable schema.org markup. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and a low Moz Domain Authority of 34/100.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to AN2 Therapeutics: AmTrust International (71/100), AMT Imaging (71/100), Anadolu Sağlık Merkezi Hastanesi (71/100), Animed Direct (71/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.